Skip to main content

. 1982 Nov;14(5):746–747. doi: 10.1111/j.1365-2125.1982.tb04969.x

Absorption of mexiletine after treatment with gastric antacids.

P Herzog, K H Holtermüller, W Kasper, T Meinertz, D Trenk, E Jähnchen

PMCID: PMC1427488 PMID: 7138757

746

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Campbell N. P., Kelly J. G., Adgey A. A., Shanks R. G. Mexiletine in normal volunteers. Br J Clin Pharmacol. 1978 Oct;6(4):372–373. doi: 10.1111/j.1365-2125.1978.tb00868.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Campbell N. P., Kelly J. G., Adgey A. A., Shanks R. G. The clinical pharmacology of mexiletine. Br J Clin Pharmacol. 1978 Aug;6(2):103–108. doi: 10.1111/j.1365-2125.1978.tb00833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Holtermüller K. H., Herzog P., Hissnauer K. H., Kühl H. J., Walther C. Uberlegungen zur Neutralisationskapazität von Antazida. Z Gastroenterol. 1981 Nov;19(11):725–727. [PubMed] [Google Scholar]
Häselbarth V., Doevendans J. E., Wolf M. Kinetics and bioavailability of mexiletine in healthy subjects. Clin Pharmacol Ther. 1981 Jun;29(6):729–736. doi: 10.1038/clpt.1981.103. [DOI] [PubMed] [Google Scholar]
Opie L. H. Drugs and the heart. IV. Antiarrhythmic agents. Lancet. 1980 Apr 19;1(8173):861–868. doi: 10.1016/s0140-6736(80)91364-1. [DOI] [PubMed] [Google Scholar]
Prescott L. F., Pottage A., Clements J. A. Absorption, distribution and elimination of mexiletine. Postgrad Med J. 1977;53 (Suppl 1):50–55. [PubMed] [Google Scholar]
Wing L. M., Meffin P. J., Grygiel J. J., Smith K. J., Birkett D. J. The effect of metoclopramide and atropine on the absorption of orally administered mexiletine. Br J Clin Pharmacol. 1980 May;9(5):505–509. [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES